SHG Loan Note Conversion of Shares

9th July 2015

09 July 2015
("Sutherland Health Group" or "the Company")
The Board of Sutherland Health Group plc, a national supplier of patient hygiene, sexual health and diagnostic products to customers including the NHS announces that Elite Webb Capital Smaller Companies Income & Growth Fund has converted £50,000 of its £200,000 Loan Notes into equity of the Company at an agreed price of 0.75p per share. This equates to 6,666,667 New Ordinary Shares.
The total number of shares in issue is now 84,803,628
Shareholders that have in excess of 3% are            
    Shareholder           ___________-___ _______ 
  Number of Shares     ________________


% of shares in issue  ________________

George Sutherland*          25,018,800 29.50%
Elite Webb Capital Smaller Companies
6,666,667 7.86%
Athol Gold and Value Ltd  4,000,000   4.72%
Rhys Summerton   4,000,000      4.72%
Sutherland Retirement Benefits Pension Fund**   3,402,972   4.01%
Winterflood Securities Ltd      3,313,742   3.91%
Suzanne Sutherland  3,044,540  3.59%
Majedie Investments   3,000,000          3.54%
Total       52,446,721 61.85%
*Includes 45,000 shares owned by his wife
** Sutherland RBS Pension Fund is for the benefit of George Sutherland
The Directors shareholdings are 30,156,468 ordinary shares representing 35.60% of the total number of shares in issue.
The Directors of the Issuer accept responsibility for this announcement.
Sutherland Health Group Plc
John French, Chairman
T: 07836 722482
Nick Michaels and Jon Isaacs
Alfred Henry Corporate Finance Ltd
T: 0207 251 3762
Notes to Editors:
Sutherland Health Group Plc is a national supplier of personal care; patient hygiene, sexual health and diagnostic products to the UK National Health Service (NHS) and other UK customers. Its aim is to supply innovative solutions to current health issues by studying current trends and working alongside leading professionals who also work within the health sector.
The company is committed to developing and marketing high quality brands and products that will benefit health professionals and consumers alike in many areas of health. The Group has established its own brands: Condomania® Condoms; Sutherland® Patient Hygiene and Personal Care; Lubricating Jelly; and Vision® pregnancy and gynaecology diagnostics. These products have already become established within the NHS business.
The Group is ISO and MHRA registered, and at present principally manufactures and operates within the United Kingdom.
For further information on the Company visit


Latest news RSS


Sutherland at Procurex Wales 2017

Sutherland at Procurex Wales 2017


Final Results 30th September 2016

Sutherland Health Group Final Results September 2016


Sutherland Attending European Midwives Conference

Sutherland Attending EMA Conference

Sign up


For further information, please read our Privacy Policy.